Notably agomelatine, an antidepressant with melatonergic agonist and 5-HT2C antagonist properties, is now considered as a possible compound for the treatment of anxiety disorders including PTSD as it alleviates anxiety symptoms in animal models19,20 and in humans21 while presenting a good tolerability profile in patients21. The gene discussed is HTR2C; the disease is Anxiety.